Cargando…
Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms
The mechanisms involved in progression from monoclonal gammopathy of undetermined significance (MGUS) and smoldering myeloma (SMM) to malignant multiple myeloma (MM) and plasma cell leukemia (PCL) are poorly understood but believed to involve the sequential acquisition of genetic hits. We performed...
Autores principales: | Walker, Brian A, Wardell, Christopher P, Melchor, Lorenzo, Brioli, Annamaria, Johnson, David C, Kaiser, Martin F, Mirabella, Fabio, Lopez-Corral, Lucia, Humphray, Sean, Murray, Lisa, Ross, Mark, Bentley, David, Gutiérrez, Norma C., Garcia-Sanz, Ramón, San Miguel, Jesus, Davies, Faith E, Gonzalez, David, Morgan, Gareth J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3916874/ https://www.ncbi.nlm.nih.gov/pubmed/23817176 http://dx.doi.org/10.1038/leu.2013.199 |
Ejemplares similares
-
Investigating the Interplay between Myeloma Cells and Bone Marrow Stromal Cells in the Development of Drug Resistance: Dissecting the Role of Epigenetic Modifications
por: Schütt, Jacqueline, et al.
Publicado: (2021) -
Multilayer intraclonal heterogeneity in chronic myelomonocytic leukemia
por: Beke, Allan, et al.
Publicado: (2020) -
Inter- and intraclonal diversity in the antibody response to influenza hemagglutinin
Publicado: (1985) -
Intraclonal Protein Expression Heterogeneity in Recombinant CHO Cells
por: Pilbrough, Warren, et al.
Publicado: (2009) -
IgIDivA: immunoglobulin intraclonal diversification analysis
por: Zaragoza-Infante, Laura, et al.
Publicado: (2022)